Bill Text: NJ S1028 | 2022-2023 | Regular Session | Amended


Bill Title: Establishes "Kidney Disease Prevention and Education Task Force."

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2023-02-13 - Reported from Senate Committee with Amendments, 2nd Reading [S1028 Detail]

Download: New_Jersey-2022-S1028-Amended.html

[First Reprint]

SENATE, No. 1028

STATE OF NEW JERSEY

220th LEGISLATURE

 

INTRODUCED JANUARY 31, 2022

 


 

Sponsored by:

Senator  TROY SINGLETON

District 7 (Burlington)

 

 

 

 

SYNOPSIS

     Establishes "Kidney Disease Prevention and Education Task Force."

 

CURRENT VERSION OF TEXT

     As reported by the Senate Health, Human Services and Senior Citizens Committee on February 13, 2023, with amendments.

  


An Act establishing the "Kidney Disease Prevention and Education Task Force."

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.  The Legislature finds and declares that:

       a.  Chronic kidney disease is the ninth leading cause of death in the United States and among New Jersey residents, with about 1,600 deaths occurring in the State each year.

     b.  An estimated 37 million people in the United 1[State] States1 have chronic kidney disease and over 200,000 people in the State of New Jersey are living with the disease.

     c.  African-Americans develop kidney failure at a rate of nearly four to one compared to Caucasians, and Hispanics have a 30 percent higher risk of developing kidney failure compared to Caucasians.

     d.  Early stage chronic kidney disease has no signs or symptoms and without early detection, can progress to kidney failure.

     e.  Although dialysis is a life-extending treatment, the best and most cost-effective treatment for kidney failure is a kidney transplant. Currently, the average waiting time for a transplant 1[can last upwards of three to five years]1 at most transplant centers 1is three to five years1 ; 1[and]1 nationally, 12 people die each day from kidney disease while waiting 1for a transplant1 .

     f.  If chronic kidney disease is detected early and managed appropriately, the individual can receive treatment sooner to help protect the kidneys, slow or even stop deterioration in kidney function, and reduce the risk of associated cardiovascular complications.

     g.  1[In light of the coronavirus disease 2019 (COVID-19) pandemic and the increased risk of infection for patients with pre-existing conditions and of COVID-19 patients developing acute kidney disease] Because individuals with kidney disease may also experience complications from prevalent infections and communicable diseases, such as COVID-19, which can adversely affect kidney health and even cause people to develop kidney diseases1  , it is imperative to provide support to individuals with kidney disease.

 

     2.    a.  There is established in the Department of Health, the "Kidney Disease Prevention and Education Task Force."  The purpose of this task force 1[is] shall be1 to:

     (1)  develop and implement a public awareness campaign about the benefits of the early detection and treatment of kidney disease that includes, but is not limited to, health education programs, preventative screenings, and social media, television, and radio outreach;

     (2)  examine racial disparities in the rates of chronic kidney disease, kidney transplantations, and 1[living and deceased kidney]1 donations 1from living and deceased donors1 and identify opportunities to promote health equity; and

     (3)  make recommendations in the implementation of a cost-effective plan for early screening, diagnosis, and treatment of chronic kidney disease Statewide.

     b.  The task force shall consist of 11 members as follows:

     (1)  1the Commissioner of Health or the commissioner's designee, who shall serve ex officio;

     (2)  the Director of the Office of Minority and Multicultural Health in the Department of Health or the director's designee, who shall serve ex officio;

     (3)1  one 1public1 member 1[of the General Assembly] who has experience with kidney disease and health care1, appointed by the Speaker of the General Assembly 1[, who shall serve as co-chairperson]1 ;

     1[(2)] (4)1  one 1public1 member 1[of the General Assembly] who has experience with kidney disease and health care1 , appointed by the Assembly Minority Leader;

     1[(3)] (5)1  one 1public1 member 1[of the Senate] who has experience with kidney disease and health care1, appointed by the President of the Senate 1[, who shall serve as co-chairperson]1 ;

     1[(4)] (6)1  one 1public1 member 1[of the Senate] who has experience with kidney disease and health care1, appointed by the Senate Minority Leader 1[;

      (5)  the Commissioner of Health or the commissioner's designee, who shall serve ex officio;

     (6)  the Director of the Office of Minority and Multicultural Health or the director's designee, who shall serve ex officio]1 ; and

     (7) five public members, who shall be appointed by the Governor, as follows:  one nephrologist; one primary care physician; one member who is a pharmaceutical representative that works with existing kidney medication; one member who is a representative from a leading dialysis center; and one member who has chronic kidney disease between Stages 2-4 that is healthy enough to participate and is not in one of the previous membership categories set forth in this paragraph. 

     1c.1  Vacancies in the membership of the task force shall be filled in the same manner 1as is1 provided for the original appointments.

     1[c.] d.1  The members of 1[this] the1 task force shall be appointed within 30 days after the effective date of this act.  The task force shall organize as soon as practicable following the appointment of its members 1and shall select a chairperson from among its members1 .  The presence of six members shall constitute a quorum.

     1[d.] e.1  The task force 1[will] shall1 meet regularly 1at times1 as 1shall be determined by1 the task force 1[determines]1 , or at the call of a majority of the task force's membership.

     1[e.] f.1  All meetings of the task force shall be open to the public.  Agendas, minutes, documents, and testimony from all meetings shall be posted on the Department of Health's Internet website.

     1[f.] g.1  The 1[public]1 members 1of the task force1 shall serve without compensation.

     1[e.] h.1  The Department of Health shall provide stenographic, clerical, and other administrative assistants and professional staff as the task force requires to carry out its work.  The task force shall be entitled to call to its assistance and avail of the services of the employees of any State, county, or municipal department, board, bureau, commission, or agency as the task force may require and as may be available for the task force's purposes.

 

     3.  1a.1  The task force shall present a report of its findings and recommendations to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), to the Legislature no later than two years after the organization of the task force.

     1b.  In the event that the report required to be developed pursuant to subsection a. of  this section is not submitted to the Governor and the Legislature within two years after the effective date of this act, the chairperson of the task force shall appear before the committee of first reference in which this act was considered in each House, or before another standing reference committee in the General Assembly as may be determined by the Speaker of the General Assembly and in the Senate as may be determined by the President of the Senate, to explain why the report has not yet been submitted and the steps the task force is taking to ensure the report is prepared and submitted.  Thereafter, for such time as the report required pursuant to subsection a. of this section has not been submitted, the Speaker of the General Assembly shall have the authority to require the chairperson of the task force to appear before any appropriate General Assembly standing reference committee to explain why the report has not been submitted and the steps that are being taken to ensure the report is prepared and submitted, and the President of the Senate shall have the authority to require the chairperson of the task force to appear before any appropriate Senate standing reference committee to explain why the report has not been submitted and the steps that are being taken to ensure the report is prepared and submitted.1

     4.  This act shall take effect immediately, and the task force shall expire 30 days after the issuance of its report.

feedback